- What we do
-
-
Routes of delivery
- Oral
- Nasal
- Pulmonary
- Parenteral
-
Development stage
- Pre-clinical
- Phase I to Phase II
- Phase III - Commercial
Our Approach
- Project Management
-
- About us
-
-
A CDMO like no other
- About Us
- Our Facilities
- Our History
- Awards and Achievements
-
Leadership Expertise
- Executive Leadership Team
- Board of Directors
- Careers
-
-
- Resources
- Events
- Contact
We are experts in oral, nasal and pulmonary delivery – able to support you to Phase I quickly or help you transition into Phase II and scale up to Phase III.
Meet our Chief Technical Officer, Ian Lafferty at BOS Manchester to discover more about how we can bring success to your drug development journey.
Venue
Manchester Central
Windmill Street, Manchester, M2 3GX, UK
Discover more about our integrated CDMO services and expertise in oral, nasal and pulmonary dosage forms.
Whitepaper: Trainsitioning From Phase I to Phase II
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Meet our experts
Dr. Richard Johnson
Chief Scientific Officer & Founder
Dr. Ian Lafferty
Chief Technical Officer
Laura Mason
Director of Pharmaceutical Sciences
Paul Kelsall
Director of Clinical Manufacturing
Helen Gisby
Director of Analytical Services
Matt Chillman
Principal Scientist
Request a meeting
Connect with our experts at BOS Manchester and request a meeting to learn more about our integrated CDMO services.